Misha Lozovik

JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity.

OFI focuses on delivering long-term results through active management and seeing opportunities where others may not. The firm’s methods of security analysis may include economic analysis, fundamental analysis, technical analysis, quantitative analysis and top-down analysis. OFI’s investment strategies may also be guided by (a) the investment objectives, policies, strategies, and restrictions set forth in an advisory or sub-advisory agreement, (b) any offering document or other governing document applicable to a client for whom OFI provides advisory services, and (c) applicable legal and regulatory requirements. OFI offers investment strategies in the following broad asset classes: equities, fixed income, alternatives and multi-asset. Equities include main street equity, small and mid cap growth equity, value and income equity, emerging markets equity and global equity. Fixed income has investment grade debt, high yield corporate debt, global debt, Rochester municipals, multi-sector fixed income and cash strategies. Alternatives asset class includes alternative strategies, real estate, gold and special minerals and global infrastructure securities.

Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments.

Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million.

Functions as a College/University

BFM utilizes fixed-income strategies that are actively managed, model or index based. The firm generally employs an active investment style that emphasizes rotation among different types of debt on a relative value basis, specific security selection, quantitative analysis of each security and the portfolio as a whole and intensive credit analysis and review. They utilize a risk-controlled, systematic process for portfolio construction and alpha generation.

Functions as a College/University

Provides investment advice